These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30153114)

  • 1. Appearance/Image- and Performance-Enhancing Drug Users: A Forensic Approach.
    Lusetti M; Licata M; Silingardi E; Bonsignore A; Palmiere C
    Am J Forensic Med Pathol; 2018 Dec; 39(4):325-329. PubMed ID: 30153114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological changes in anabolic androgenic steroid users.
    Lusetti M; Licata M; Silingardi E; Reggiani Bonetti L; Palmiere C
    J Forensic Leg Med; 2015 Jul; 33():101-4. PubMed ID: 26048507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sudden or unnatural deaths involving anabolic-androgenic steroids.
    Darke S; Torok M; Duflou J
    J Forensic Sci; 2014 Jul; 59(4):1025-8. PubMed ID: 24611438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Steroids are a growing problem at gyms].
    Rane A; Rosén T; Skårberg K; Heine L; Ljungdahl S
    Lakartidningen; 2013 Sep 25-Oct 8; 110(39-40):1741-6. PubMed ID: 24245430
    [No Abstract]   [Full Text] [Related]  

  • 5. Superheroes - Image and performance enhancing drug (IPED) use within the UK, social media and gym culture.
    Richardson A; Dixon K; Kean J
    J Forensic Leg Med; 2019 May; 64():28-30. PubMed ID: 30921558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases.
    Montisci M; El Mazloum R; Cecchetto G; Terranova C; Ferrara SD; Thiene G; Basso C
    Forensic Sci Int; 2012 Apr; 217(1-3):e13-8. PubMed ID: 22047750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use.
    Baggish AL; Weiner RB; Kanayama G; Hudson JI; Lu MT; Hoffmann U; Pope HG
    Circulation; 2017 May; 135(21):1991-2002. PubMed ID: 28533317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychological and physical impact of anabolic-androgenic steroid dependence.
    Ip EJ; Lu DH; Barnett MJ; Tenerowicz MJ; Vo JC; Perry PJ
    Pharmacotherapy; 2012 Oct; 32(10):910-9. PubMed ID: 23033230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic dilemma of pathological appearance and performance enhancing drug use.
    Hildebrandt T; Lai JK; Langenbucher JW; Schneider M; Yehuda R; Pfaff DW
    Drug Alcohol Depend; 2011 Mar; 114(1):1-11. PubMed ID: 21115306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance enhancing drug abuse and cardiovascular risk in athletes: implications for the clinician.
    Angell PJ; Chester N; Sculthorpe N; Whyte G; George K; Somauroo J
    Br J Sports Med; 2012 Nov; 46 Suppl 1():i78-84. PubMed ID: 23097484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Still unclear whether steroids induces addiction on its own].
    Hallberg M; Nyberg F
    Lakartidningen; 2013 Sep 25-Oct 8; 110(39-40):1736-9. PubMed ID: 24245429
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiac hypertrophy in deceased users of anabolic androgenic steroids: an investigation of autopsy findings.
    Far HR; Ågren G; Thiblin I
    Cardiovasc Pathol; 2012; 21(4):312-6. PubMed ID: 22104006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicological and pathological findings in a series of buprenorphine related deaths. Possible risk factors for fatal outcome.
    Seldén T; Ahlner J; Druid H; Kronstrand R
    Forensic Sci Int; 2012 Jul; 220(1-3):284-90. PubMed ID: 22565115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Changing Drug Culture: Use and Misuse of Appearance- and Performance-Enhancing Drugs.
    Albertson TE; Chenoweth JA; Colby DK; Sutter ME
    FP Essent; 2016 Feb; 441():30-43. PubMed ID: 26881771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic remodeling of the myocardium in a weightlifter taking anabolic steroids.
    Campbell SE; Farb A; Weber KT
    Blood Press; 1993 Sep; 2(3):213-6. PubMed ID: 8205315
    [No Abstract]   [Full Text] [Related]  

  • 16. Performance enhancing drugs (doping agents) and sudden death--a case report and review of the literature.
    Hausmann R; Hammer S; Betz P
    Int J Legal Med; 1998; 111(5):261-4. PubMed ID: 9728754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The difference in the flow-mediated response between steroid users and non-users.
    Atkinson G
    Eur J Prev Cardiol; 2014 Mar; 21(3):339. PubMed ID: 23720525
    [No Abstract]   [Full Text] [Related]  

  • 18. Heavy Testosterone Use Among Bodybuilders: An Uncommon Cohort of Illicit Substance Users.
    Westerman ME; Charchenko CM; Ziegelmann MJ; Bailey GC; Nippoldt TB; Trost L
    Mayo Clin Proc; 2016 Feb; 91(2):175-82. PubMed ID: 26769184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycythemia and renal infarction in a bodybuilder.
    Ammatuna E; Nijziel MR
    QJM; 2014 Aug; 107(8):661-2. PubMed ID: 24557731
    [No Abstract]   [Full Text] [Related]  

  • 20. The dark side of sports: using steroids may harm your liver.
    Machado MV; Cortez-Pinto H
    Liver Int; 2011 Mar; 31(3):280-1. PubMed ID: 21281427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.